About IniXium
IniXium is a company based in Laval (Canada) founded in 2014 was acquired by NuChem Sciences in October 2022.. The company has 6 employees as of December 31, 2024. IniXium offers products and services including Protein Production, Biophysical Characterization, Protein Crystallography, Fragment Screening, and Biologics and Biosimilars. IniXium operates in a competitive market with competitors including Adroit Science, Nextal Biotechnology, ProteoPlex, Crystallophore and Structure Based Design, among others.
- Headquarter Laval, Canada
- Employees 6 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
6
as on Dec 31, 2024
-
Acquired by
NuChem Sciences
(Oct 31, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IniXium
IniXium offers a comprehensive portfolio of products and services, including Protein Production, Biophysical Characterization, Protein Crystallography, Fragment Screening, and Biologics and Biosimilars. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for producing proteins to support drug discovery research.
Methods to characterize biomolecules for drug development applications.
Techniques for determining protein structures in drug discovery.
Process to screen fragments for potential drug candidates.
Services for developing and analyzing biologic drugs and biosimilars.
Funding Insights of IniXium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IniXium
IniXium has secured backing from 1 investor. Prominent investors backing the company include NuChem Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chemical research services are provided by NuChem Sciences in Canada.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IniXium
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IniXium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inixium Comparisons
Competitors of IniXium
IniXium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adroit Science, Nextal Biotechnology, ProteoPlex, Crystallophore and Structure Based Design, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Crystallization services are provided for drug discovery and formulation development.
|
|
| domain | founded_year | HQ Location |
Enabling solutions for protein crystallization are provided to crystallographers.
|
|
| domain | founded_year | HQ Location |
Delivers specialized services for protein crystallography studies and research solutions.
|
|
| domain | founded_year | HQ Location |
Develops and supplies tools for structural biology and macromolecular crystallography research.
|
|
| domain | founded_year | HQ Location |
Provides biotech services for protein analysis and drug discovery research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about IniXium
When was IniXium founded?
IniXium was founded in 2014.
Where is IniXium located?
IniXium is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
How many employees does IniXium have?
As of Dec 31, 2024, the latest employee count at IniXium is 6.
What does IniXium do?
IniXium offers drug discovery related protein services. The services include Protein production and binding analysis ( Large-scale protein production and purification, Dynamic Light Scattering (DLS) analysis, Biophysical molecular interaction analysis by ITC and, SPR ), and Protein crystallography (Complete Gene to Structure project, Protein crystallization screen and optimization, De novo 3D structure determination, Protein-ligand complex structure determination, Lead optimization support, Fast throughput structure determination of complex, Rapid access to synchrotron light sources, Fragment screening campaign, High throughput crystal soaking, and High-throughput co-crystallization).
Who are the top competitors of IniXium?
IniXium's top competitors include Nextal Biotechnology, Adroit Science and SeNA Research.
What products or services does IniXium offer?
IniXium offers Protein Production, Biophysical Characterization, Protein Crystallography, Fragment Screening, and Biologics and Biosimilars.
Who are IniXium's investors?
IniXium has 1 investor. Key investors include NuChem Sciences.